DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1385]
Bulk Manufacturer of Controlled Substances Application: S&B Pharma LLC DBA
Norac Pharma
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
SUMMARY: S&B Pharma LLC DBA Norac Pharma has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es), and applicants
therefore, may submit electronic comments on or objections to the issuance of the proposed
registration on or before [INSERT DATE 60 DAYS AFTER DATE OF PUBLICATION IN
THE FEDERAL REGISTER]. Such persons may also file a written request for a hearing on
the application on or before [INSERT DATE 60 DAYS AFTER DATE OF PUBLICATION
IN THE FEDERAL REGISTER].
ADDRESSES: The Drug Enforcement Administration requires that all comments be
submitted electronically through the Federal eRulemaking Portal, which provides the ability
to type short comments directly into the comment field on the Web page or attach a file for
lengthier comments. Please go to https://www.regulations.gov and follow the online
instructions at that site for submitting comments. Upon submission of your comment, you
will receive a Comment Tracking Number. Please be aware that submitted comments are not
instantaneously available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully submitted and
there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is
notice that on April 30, 2024, S&B Pharma LLC DBA Norac Pharma, 405 South Motor
Avenue, Azusa, California 91702, applied to be registered as a bulk manufacturer of the
following basic class(es) of controlled substance(s):
Controlled Substance
Gamma Hydroxybutyric Acid

Drug Code
Schedule
I

The company plans to manufacture the above listed controlled substance for internal
research and for development purposes as part of the process in seeking Food and Drug
Administration approval prior to distribution to customers. No other activity for this drug
code is authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.

[FR Doc. 2024-14910 Filed: 7/5/2024 8:45 am; Publication Date: 7/8/2024]